← Open Payments lookup

PHILIP MALINAS: Open Payments

NPI 1700934825 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$16,680 in 159 payments from 17 companies in 2025. Trend: 2023 $9,858 · 2024 $11,621 · 2025 $16,680

Speaker / faculty: $11,772Food & beverage: $3,216Travel & lodging: $1,133Consulting: $560
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$14,033
ABBVIE INC.27$478
Neurocrine BioSciences, Inc.10$337
E.R. Squibb & Sons, L.L.C.12$296
Vanda Pharmaceuticals Inc.15$263
Otsuka America Pharmaceutical, Inc.10$224
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$217
Collegium Pharmaceutical, Inc.21$201
Tris Pharma Inc9$172
Alkermes, Inc.7$159

Products named: AUSTEDO XR, VRAYLAR, INGREZZA, COBENFY, CAPLYTA, Jornay PM, FANAPT, Dyanavel XR.

Industry payments across NV — which companies pay providers there.